BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Daxko Wins Silver in Fourth Consecutive Stevie® Award for Exceptional Customer Service

  Daxko was presented with a Silver Stevie® Award in the Customer Service Department of the Year category in the 13th annual Stevie Awards for Sales & Customer Service.

  February 27, 2019

   · 

  2 min read
• Drug Development

  Catalyst Pharmaceuticals Announces Publication of Phase 3 Clinical Trial Data for Firdapse® for the Treatment of Lambert-Eaton Myasthenic Syndrome

  The positive topline results from this trial were previously announced, but the full results of safety, efficacy, and other clinical data are now available online.

  February 27, 2019

   · 

  3 min read
• Pharma in South East Asia booming as CPhI opens event for the first time in Thailand

  CPhI South East Asia’s first visit to Bangkok has stimulated a market resurgence, with pre-registration numbers tripling and exhibition growth of 50%

  February 27, 2019

   · 

  5 min read
• Business

  Immatics Announces Clinical Trial Collaboration in Immunotherapy for Solid Cancers

  Study of investigational personalized T-cell therapy IMA101 expanded to explore combination with anti-PDL1 antibody

  February 27, 2019

   · 

  4 min read
• Policy

  OtiTopic Granted Two Patents Covering its Dry Powder Inhaled Aspirin for the Treatment of Suspected Myocardial Infarction

  OtiTopic, Inc. announced that the U.S. Patent and Trade Office has granted two new patents protecting intellectual property related to its lead candidate, OTI-0726, a novel inhaled rapid-onset aspirin formulation in development for the treatment of suspected myocardial infarction.

  February 27, 2019

   · 

  3 min read
• Quality First International launches post-Brexit UK Responsible Person Programme for medical device manufacturers

  London-based medical device regulatory consultancy Quality First International now offers post-Brexit UK representation services that will become mandatory for medical device manufacturers located outside the UK

  February 27, 2019

   · 

  2 min read
• Biotech Beach

  Take Action for World Rare Disease Day on February 28, 2019

  In honor of World Rare Disease Day tomorrow, Global Genes®, a leading rare disease patient advocacy organization, takes action across the United States as representatives divide and conquer to drive forward momentum for rare disease patients and advocates.

  February 27, 2019

   · 

  3 min read
• Business

  Lauren Smith, MD, MPH, Joins Blue Cross Blue Shield of Massachusetts board of directors

  New member brings 25 years of experience in health care delivery and management, public policy, and public health

  February 27, 2019

   · 

  2 min read
• MR Solutions’ high-field multi-modality, cryogen-free MRI system on display at EMIM

  MR Solutions’ latest compact preclinical, multi-modality MRI systems will be on display at the 14th European Molecular Imaging Meeting (EMIM 2019) being held at the Scottish Event Campus in Glasgow on 19 to 22 March, 2019.

  February 27, 2019

   · 

  2 min read
• MEDTRONIC ANNOUNCES FDA CLEARANCE AND U.S. LAUNCH OF THE ACCURIAN RADIO FREQUENCY SYSTEM FOR NERVE TISSUE ABLATION

  Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian™ RF ablation platform, which conducts radio frequency (RF) ablation of nerve tissues

  February 27, 2019

   · 

  4 min read